Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Tabula Rasa Healthcare Inc (TRHC)

Tabula Rasa Healthcare Inc (TRHC)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,349,490
  • Shares Outstanding, K 23,021
  • Annual Sales, $ 284,710 K
  • Annual Income, $ -32,440 K
  • 60-Month Beta 1.15
  • Price/Sales 4.47
  • Price/Cash Flow 29.41
  • Price/Book 7.09

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 11 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/20
See More
  • Average Estimate -0.22
  • Number of Estimates 6
  • High Estimate -0.13
  • Low Estimate -0.44
  • Prior Year 0.13
  • Growth Rate Est. (year over year) -269.23%

Price Performance

See More
Period Period Low Period High Performance
1-Month
52.95 +8.94%
on 06/30/20
61.73 -6.55%
on 06/23/20
-0.53 (-0.90%)
since 06/16/20
3-Month
51.67 +11.63%
on 05/29/20
66.09 -12.72%
on 04/29/20
+1.12 (+1.99%)
since 04/16/20
52-Week
33.04 +74.59%
on 03/17/20
69.72 -17.26%
on 02/21/20
+4.36 (+8.19%)
since 07/16/19

Most Recent Stories

More News
CERN vs. TRHC: Which Stock Should Value Investors Buy Now?

CERN vs. TRHC: Which Stock Is the Better Value Option?

CERN : 71.44 (-0.52%)
TRHC : 57.44 (-2.01%)
Tabula Rasa HealthCare Launches MedWise(TM) SaaS Technology Integration for Community Pharmacists

Tabula Rasa HealthCare, Inc (TRHC) (NASDAQ: TRHC), a healthcare technology company advancing the field of medication safety, announced the launch of MedWise(TM) to its PrescribeWellness (PW) community...

TRHC : 57.44 (-2.01%)
Tabula Rasa HealthCare (TRHC) in Focus: Stock Moves 5.2% Higher

Tabula Rasa HealthCare (TRHC) saw a big move last session, as its shares jumped more than 5% on the day, amid huge volumes.

CERN : 71.44 (-0.52%)
TRHC : 57.44 (-2.01%)
CERN or TRHC: Which Is the Better Value Stock Right Now?

CERN vs. TRHC: Which Stock Is the Better Value Option?

CERN : 71.44 (-0.52%)
TRHC : 57.44 (-2.01%)
Tabula Rasa HealthCare's Risk Adjustment Division Launches New Online Training for Physicians and Other Providers

Tabula Rasa HealthCare (TRHC) (NASDAQ:TRHC), a healthcare technology company advancing the field of medication safety, has launched the "Clinical Documentation Excellence" (CDE) Online Education series...

TRHC : 57.44 (-2.01%)
Tabula Rasa HealthCare(R) Expands Clinical Services for Patients Enrolled in Medicare Advantage

Tabula Rasa HealthCare, Inc. ("TRHC") (NASDAQ: TRHC), a healthcare technology company advancing the field of medication safety, announced it is expanding its clinical services to include special needs...

TRHC : 57.44 (-2.01%)
TRHC and Equiscript Launch an Advanced Medication Adherence Reporting and Analytics Program

Tabula Rasa HealthCare(R) Corporation (NASDAQ: TRHC), a healthcare technology company advancing the field of medication safety has partnered with Equiscript, a 340B patient pharmacy care and technology...

TRHC : 57.44 (-2.01%)
TRHC's MedWise Risk Score(TM) Reduces the Odds of Adverse Drug Events, Keeping Patients Safer

Article published in peer-reviewed Pharmacy showcases the power of TRHC's multi-drug medication decision support tool

TRHC : 57.44 (-2.01%)
TRHC Fills the Information Gap on COVID-19 Proposed Therapies with a New Digital Resource

Tabula Rasa HealthCare(R) Corporation (NASDAQ: TRHC), a healthcare technology company advancing the field of medication safety, today published on the web the TRHC COVID-19 Treatment and Therapy Digital...

TRHC : 57.44 (-2.01%)
HMSY or TRHC: Which Is the Better Value Stock Right Now?

HMSY vs. TRHC: Which Stock Is the Better Value Option?

HMSY : 32.50 (-1.28%)
TRHC : 57.44 (-2.01%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Trade TRHC with:

Business Summary

Tabula Rasa HealthCare, Inc. is a provider of patient-specific, data-driven technology and solutions which enable healthcare organizations to optimize medication regimens to improve patient outcomes, reduce hospitalizations, lower healthcare costs and manage risk. The company's cloud-based software applications...

See More

Key Turning Points

2nd Resistance Point 60.63
1st Resistance Point 59.63
Last Price 57.44
1st Support Level 56.77
2nd Support Level 54.92

See More

52-Week High 69.72
Last Price 57.44
Fibonacci 61.8% 55.71
Fibonacci 50% 51.38
Fibonacci 38.2% 47.05
52-Week Low 33.04

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar